ÈËÆÞÖгöÊÓƵ

Mary P. Bronner
No Rating Available
(Learn About Our Rating System)

Mary P. Bronner, MD

Languages spoken: English

  • Mary P. Bronner, MD, is the Carl R. Kjeldsberg Presidential Endowed Chair Professor of Pathology. She is also a tenured professor of pathology at the ÈËÆÞÖгöÊÓƵ of Utah School of Medicine.



    At the Department of Pathology and ARUP Laboratories, and HCI, Dr. Bronner directs all patient care, education, and research efforts within the Anatomic Pathology and Molecular Oncology Division. Her research focuses on molecular oncology and early detection and prevention of gastrointestinal neoplasia arising in chronic inflammatory diseases, such as chronic pancreatitis, Helicobacter pylori gastritis and idopathic inflammatory bowel disease.

    Dr. Bronner holds the Dr. Carl R. Kjeldsberg Presidential Endowed Chair in Pathology. She served as the elected President of the GI Pathology Society, and as an elected Council Memeber of the United States and Canadian Academy of Pathology. She was the recipient of the prestigious Arthur Purdy Stout Prize, which recognizes surgical pathologists under the age of 45 whose research have had a major impact on diagnostic pathology. Dr. Bronner is also certified by the American Board of Pathology in Anatomic Pathology. She completed her pathology residency training and chief residency at the Hospital of the ÈËÆÞÖгöÊÓƵ of Pennsylvania in Philadelphia. She received her medical degree from the ÈËÆÞÖгöÊÓƵ of Pennsylvania and has been on the faculty at the ÈËÆÞÖгöÊÓƵ of Pennsylvania, the ÈËÆÞÖгöÊÓƵ of Washington, the Cleveland Clinic Foundation prior to joining the ÈËÆÞÖгöÊÓƵ of Utah and ARUP Laboratories.

    Specialties

    Board Certification

    American Board of Pathology (Anatomic)

  • Mary P. Bronner, MD, is the Carl R. Kjeldsberg Presidential Endowed Chair Professor of Pathology. She is also a tenured professor of pathology at the ÈËÆÞÖгöÊÓƵ of Utah School of Medicine.



    At the Department of Pathology and ARUP Laboratories, and HCI, Dr. Bronner directs all patient care, education, and research efforts within the Anatomic Pathology and Molecular Oncology Division. Her research focuses on molecular oncology and early detection and prevention of gastrointestinal neoplasia arising in chronic inflammatory diseases, such as chronic pancreatitis, Helicobacter pylori gastritis and idopathic inflammatory bowel disease.

    Dr. Bronner holds the Dr. Carl R. Kjeldsberg Presidential Endowed Chair in Pathology. She served as the elected President of the GI Pathology Society, and as an elected Council Memeber of the United States and Canadian Academy of Pathology. She was the recipient of the prestigious Arthur Purdy Stout Prize, which recognizes surgical pathologists under the age of 45 whose research have had a major impact on diagnostic pathology. Dr. Bronner is also certified by the American Board of Pathology in Anatomic Pathology. She completed her pathology residency training and chief residency at the Hospital of the ÈËÆÞÖгöÊÓƵ of Pennsylvania in Philadelphia. She received her medical degree from the ÈËÆÞÖгöÊÓƵ of Pennsylvania and has been on the faculty at the ÈËÆÞÖгöÊÓƵ of Pennsylvania, the ÈËÆÞÖгöÊÓƵ of Washington, the Cleveland Clinic Foundation prior to joining the ÈËÆÞÖгöÊÓƵ of Utah and ARUP Laboratories.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Anatomic)

    Education history

    Fellowship Anatomic Pathology Student Fellowship - Hospital of the ÈËÆÞÖгöÊÓƵ of Pennsylvania Fellow
    Wistar Institute Research - ÈËÆÞÖгöÊÓƵ of Pennsylvania Fellow
    Professional Medical Medicine - ÈËÆÞÖгöÊÓƵ of Pennsylvania M.D.
    Biology & Genetics with Honors - Cornell ÈËÆÞÖгöÊÓƵ B.S.

    Selected Publications

    Journal Article

    1. Duong VA, Enkhbayar A, Bhasin N, Senavirathna L, Preisner EC, Hoffman KL, Shukla R, Jenq RR, Cheng K, Bronner MP, Figeys D, Britton RA, Pan S, Chen R (2024). A complementary metaproteomic approach to interrogate microbiome cultivated from clinical colon biopsies. Proteomics, e2400078. ()
    2. Underhill HR, Karsy M, Davidson CJ, Hellwig S, Stevenson S, Goold EA, Vincenti S, Sellers DL, Dean C, Harrison BE, Bronner MP, Colman H, Jensen RL (2023). Subclonal Cancer Driver Mutations Are Prevalent in the Unresected Peritumoral Edema of Adult Diffuse Gliomas. Cancer Res, 84(7), 1149-1164. ()
    3. Patel N, Leffler DA, Al-Toma A, Mulder C, Elli L, Gan G, Patil P, Atsawarungruangkit A, Kuijpers KC, Del Gobbo A, Goldsmith J, Hintze Z, Pacheco MC, Vieth M, Melcher B, Salomao M, Pai R, Hart J, Olivas A, Naini B, Meyerson C, Choi WT, Kakar S, Westerhoff M, Cheng J, Gopal P, Hammer S, Moreno Prats M, Bronner MP, Robert ME (2023). Clinical Data Do Not Reliably Predict Duodenal Histology at Follow-up in Celiac Disease: A 13 Center Correlative Study. Am J Surg Pathol, 48(2), 212-220. ()
    4. Boylan KE, Kanth P, Delker D, Hazel MW, Boucher KM, Affolter K, Clayton F, Evason KJ, Jedrzkiewicz J, Pletneva M, Samowitz W, Swanson E, Bronner MP (2023). Three pathologic criteria for reproducible diagnosis of colonic sessile serrated lesion versus hyperplastic polyp. Hum Pathol, 137, 25-35. ()
    5. Tsai HY, Bronner MP, March JK, Valentine JF, Shroyer NF, Lai LA, Brentnall TA, Pan S, Chen R (2022). Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer. Cancer Lett, 549, 215915. ()
    6. Dong ZM, Fang J, Byrne KR, Bronner MP, Hale GL (2021). Histologic Mimics and Diagnostic Pitfalls of Gastrointestinal Endoscopic Lifting Media, ORISETM gel and Eleview®. Hum Pathol, 119, 28-40. ()
    7. Eisele Y, Mallea PM, Gigic B, Stephens WZ, Warby CA, Buhrke K, Lin T, Boehm J, Schrotz-King P, Hardikar S, Huang LC, Pickron TB, Scaife CL, Viskochil R, Koelsch T, Peoples AR, Pletneva MA, Bronner M, Schneider M, Ulrich AB, Swanson EA, Toriola AT, Shibata D, Li CI, Siegel EM, Figueiredo J, Janssen KP, Hauner H, Round J, Ulrich CM, Holowatyj AN, Ose J (2021). Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study. Clin Colorectal Cancer, 20(3), e165-e172. ()
    8. Himbert C, Figueiredo JC, Shibata D, Ose J, Lin T, Huang LC, Peoples AR, Scaife CL, Pickron B, Lambert L, Cohan JN, Bronner M, Felder S, Sanchez J, Dessureault S, Coppola D, Hoffman DM, Nasseri YF, Decker RW, Zaghiyan K, Murrell ZA, Hendifar A, Gong J, Firoozmand E, Gangi A, Moore BA, Cologne KG, El-Masry MS, Hinkle N, Monroe J, Mutch M, Bernadt C, Chatterjee D, Sinanan M, Cohen SA, Wallin U, Grady WM, Lampe PD, Reddi D, Krane M, Fichera A, Moonka R, Herpel E, Schirmacher P, Kloor M, von Knebel-Doeberitz M, Nattenmueller J, Kauczor HU, Swanson E, Jedrzkiewicz J, Schmit SL, Gigic B, Ulrich AB, Toriola AT, Siegel EM, Li CI, Ulrich CM, Hardikar S (2021). Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset. Cancers (Basel), 13(15). ()
    9. Affolter KE, Hellwig S, Nix DA, Bronner MP, Thomas A, Fuertes CL, Hamil CL, Garrido-Laguna I, Scaife CL, Mulvihill SJ, Underhill HR (2021). Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma. Neoplasia, 23(9), 859-869. ()
    10. Pedersen BS, Bhetariya PJ, Brown J, Kravitz SN, Marth G, Jensen RL, Bronner MP, Underhill HR, Quinlan AR (2020). Somalier: rapid relatedness estimation for cancer and germline studies using efficient genome sketches. Genome Med, 12(1), 62. ()
    11. Geijsen AJMR, Ulvik A, Gigic B, Kok DE, van Duijnhoven FJB, Holowatyj AN, Brezina S, van Roekel EH, Baierl A, Bergmann MM, Bhm J, Bours MJL, Brenner H, Breukink SO, Bronner MP, Chang-Claude J, de Wilt JHW, Grady WM, Grnberger T, Gumpenberger T, Herpel E, Hoffmeister M, Huang LC, Jedrzkiewicz JD, Keulen ETP, Kiblawi R, Klsch T, Koole JL, Kosma K, Kouwenhoven EA, Kruyt FM, Kvalheim G, Li CI, Lin T, Ose J, Pickron TB, Scaife CL, Schirmacher P, Schneider MA, Schrotz-King P, Singer MC, Swanson ER, van Duijvendijk P, van Halteren HK, van Zutphen M, Vickers K, Vogelaar FJ, Wesselink E, Habermann N, Ulrich AB, Ueland PM, Weijenberg MP, Gsur A, Ulrich CM, Kampman E (2020). Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival. JNCI Cancer Spectr, 4(5), pkaa051. ()
    12. Alpert L, Al-Sabti R, Graham RP, Pai RK, Gonzalez RS, Zhang X, Smith V, Wang HL, Westbrook L, Goldblum JR, Bakhshwin A, Shetty S, Klimstra DS, Shia J, Askan G, Robert ME, Thomas C, Frankel WL, Alsomali M, Hagen C, Mostafa ME, Feely MM, Assarzadegan N, Misdraji J, Shih AR, Agostini-Vulaj D, Meis JM, Tang S, Chatterjee D, Kang LI, Hart J, Lee SM, Smith T, Yantiss RK, Hissong EM, Gao ZH, Wu J, Resnick MB, Wu EY, Pai RK, Zhao L, Doyle LA, Chopra S, Panarelli NC, Hu S, Longacre TA, Raghavan SS, Lauwers GY, Ghayouri M, Cooper HS, Nagarathinam R, Bellizzi AM, Kakar S, Hosseini M, Rong J, Greenson JK, Lamps LW, Dong Z, Bronner MP (2020). Smooth muscle tumors of the gastrointestinal tract: an analysis of prognostic features in 407 cases. Mod Pathol, 33(7), 1410-1419. ()
    13. Deftereos G, Sandoval A, Furtado LV, Bronner M, Matynia AP (2020). Successful lung cancer EGFR sequencing from DNA extracted from TTF-1 immunohistochemistry slides: a new means to extend insufficient tissue. Hum Pathol, 97, 52-59. ()
    14. Nix DA, Hellwig S, Conley C, Thomas A, Fuertes CL, Hamil CL, Bhetariya PJ, Garrido-Laguna I, Marth GT, Bronner MP, Underhill HR (2020). The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA. PLoS One, 15(2), e0229063. ()
    15. Loeb LA, Kohrn BF, Loubet-Senear KJ, Dunn YJ, Ahn EH, OSullivan JN, Salk JJ, Bronner MP, Beckman RA (2019). Extensive subclonal mutational diversity in human colorectal cancer and its significance. Proc Natl Acad Sci U S A, 116(52), 26863-72. ()
    16. Kanth P, Boylan KE, Bronner MP, Boucher KM, Hazel MW, Yao R, Pop S, Bernard PS, Delker DA (2019). Molecular Biomarkers of Sessile Serrated Adenoma/Polyps. Clin Transl Gastroenterol, 10(12), e00104. ()
    17. Runtsch MC, Nelson MC, Lee SH, Voth W, Alexander M, Hu R, Wallace J, Petersen C, Panic V, Villanueva CJ, Evason KJ, Bauer KM, Mosbruger T, Boudina S, Bronner M, Round JL, Drummond MJ, OConnell RM (2019). Anti-inflammatory microRNA-146a protects mice from diet-induced metabolic disease. PLoS Genet, 15(2), e1007970. ()
    18. Kanth P, Hazel MW, Boucher KM, Yang Z, Wang L, Bronner MP, Boylan KE, Burt RW, Westover M, Neklason DW, Delker DA (2018). Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer. Genes Chromosomes Cancer, 58(1), 23-33. ()
    19. Jedrzkiewicz J, Bronner MP, Salama ME, Kohan J, Rowe LR, Tai D, Malmberg E, Downs-Kelly E (2018). Liver Fibrosis Quantification by Digital Whole Slide Imaging and Two Photon Microscopy with Second Harmonic Generation. 4(78).
    20. Hellwig S, Nix DA, Gligorich KM, OShea JM, Thomas A, Fuertes CL, Bhetariya PJ, Marth GT, Bronner MP, Underhill HR (2018). Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing. PLoS One, 13(7), e0197333. ()
    21. Caliskan A, Kohlmann WK, Affolter KE, Downs-Kelly E, Kanth P, Bronner MP (2017). Intramucosal lipomas of the colon implicate Cowden syndrome. Mod Pathol, 31(4), 643-651. ()
    22. Russell CW, Fleming BA, Jost CA, Tran A, Stenquist AT, Wambaugh WA, Bronner MP, Mulvey MA (2018). Context-Dependent Requirements for FimH and Other Canonical Virulence Factors in Gut Colonization by Extraintestinal Pathogenic Escherichia coli. Infect Immun, 86(3), pii: e00746-17.
    23. El Jabbour T, Ross JS, Sheehan CE, Affolter KE, Geiersbach KB, Boguniewicz A, Ainechi S, Bronner MP, Jones DM, Lee H (2017). PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry. J Clin Pathol, 71(1), 46-51. ()
    24. Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, Flores A, Mohlman J, Sorensen LK, Earl CS, Olson KA, Miao R, Waller TC, Delker D, Kanth P, Jiang L, DeBerardinis RJ, Bronner MP, Li DY, Cox JE, Christofk HR, Lowry WE, Thummel CS, Rutter J (2017). Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nat Cell Biol, 19(9), 1027-1036. ()
    25. Samadder, NJ, Valentine JF, Guthery S, Singh H, Bernstein C, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Bronner M, Ulrich N, Burt RW, Curtin K and Smith KR (2017). Colorectal cancer in inflammatory bowel diseases: A population-based study in Utah. Dig Dis Sci, 62(8), 2126-2132.
    26. Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J, Bronner MP (2016). Gastrointestinal Polyposis in Cowden Syndrome. J Clin Gastroenterol, 51(7), e60-e67. ()
    27. Underhill HR, Kitzman JO, Hellwig S, Welker NC, Daza R, Baker DN, Gligorich KM, Rostomily RC, Bronner MP, Shendure J (2016). Fragment Length of Circulating Tumor DNA. PLoS Genet, 12(7), e1006162. ()
    28. Kanth P, Bronner MP, Boucher KM, Burt RW, Neklason DW, Hagedorn CH, Delker DA (2016). Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype. Cancer Prev Res (Phila), 9(6), 456-65. ()
    29. Lynam-Lennon N, Bibby BA, Mongan AM, Marignol L, Paxton CN, Geiersbach K, Bronner MP, OSullivan J, Reynolds J, Maher SG (2016). Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma. Mol Med, 22. ()
    30. Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J, Bronner MP (2016). Morphologic characterization of hamartomatous gastrointestinal polyps in Cowden syndrome, Peutz-Jeghers syndrome, and juvenile polyposis syndrome. Hum Pathol, 49, 39-48. ()
    31. Geiersbach K, Adey N, Welker N, Elsberry D, Malmberg E, Edwards S, Downs-Kelly E, Salama M, Bronner M (2015). Digitally guided microdissection aids somatic mutation detection in difficult to dissect tumors. Cancer Genet, 209(1-2), 42-9. ()
    32. Lin J, Zhang X, Zhao Z, Welker NC, Li Y, Liu Y, Bronner MP (2016). Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing. Microrna, 5(3), 222-229. ()
    33. Kim B-W, Cho M-Y, Lee B, Shadrach B, Shergill U, Welker N, Crispin D, Shimoda S, Peng X, Li J, Bronner MP 2013 (2016). FISH Biomarkers of Gastric Cancer Risk in Helicobacter Pylori Intestinalized Pangastritis. Gastroenterology.
    34. Runtsch MC, Hu R, Alexander M, Wallace J, Kagele D, Petersen C, Valentine JF, Welker NC, Bronner MP, Chen X, Smith DP, Ajami NJ, Petrosino JF, Round JL, OConnell RM (2015). MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis. Oncotarget, 6(30), 28556-72. ()
    35. Krah NM, De La O JP, Swift GH, Hoang CQ, Willet SG, Chen Pan F, Cash GM, Bronner MP, Wright CV, MacDonald RJ, Murtaugh LC (2015). The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. Elife, 4. ()
    36. Sangle NA, Taylor SL, Emond MJ, Depot M, Overholt BF, Bronner MP (2015). Overdiagnosis of high-grade dysplasia in Barrett's esophagus: a multicenter, international study. Mod Pathol, 28(6), 758-65. ()
    37. Chen R, Pan S, Lai K, Lai LA, Crispin DA, Bronner MP, Brentnall TA (2014). Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer. World J Gastroenterol, 20(45), 17037-48. ()
    38. Lin J, Welker NC, Zhao Z, Li Y, Zhang J, Reuss SA, Zhang X, Lee H, Liu Y, Bronner MP (2014). Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity. Mod Pathol, 27(4), 602-8. ()
    39. Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, Burt RW, Hagedorn CH (2014). RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PLoS One, 9(2), e88367. ()
    40. Salk JJ, Bansal A, Lai LA, Crispin DA, Ussakli CH, Horwitz MS, Bronner MP, Brentnall TA, Loeb LA, Rabinovitch PS, Risques RA (2013). Clonal expansions and short telomeres are associated with neoplasia in early-onset, but not late-onset, ulcerative colitis. Inflamm Bowel Dis, 19(12), 2593-602. ()
    41. Affolter K, Samowitz W, Tripp S, Bronner MP (2013). BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma. Genes Chromosomes Cancer, 52(8), 748-52. ()
    42. Patil DT, Bennett AE, Mahajan D, Bronner MP (2013). Distinguishing Barrett gastric foveolar dysplasia from reactive cardiac mucosa in gastroesophageal reflux disease. Hum Pathol, 44(6), 1146-53. ()
    43. Lin J, Cao Q, Zhang J, Li Y, Shen B, Zhao Z, Chinnaiyan AM, Bronner MP (2013). MicroRNA expression patterns in indeterminate inflammatory bowel disease. Mod Pathol, 26(1), 148-54. ()
    44. Crnogorac-Jurcevic T, Chelala C, Barry S, Harada T, Bhakta V, Lattimore S, Jurcevic S, Bronner M, Lemoine NR, Brentnall TA (2013). Molecular analysis of precursor lesions in familial pancreatic cancer. PLoS One, 8(1), e54830. ()
    45. Zisman TL, Bronner MP, Rulyak S, Kowdley KV, Saunders M, Lee SD, Ko C, Kimmey MB, Stevens A, Maurer J, Brentnall TA (2012). Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Inflamm Bowel Dis, 18(12), 2240-6. ()
    46. Patil DT, Bronner MP, Portier BP, Fraser CR, Plesec TP, Liu X (2012). A five-marker panel in a multiplex PCR accurately detects microsatellite instability-high colorectal tumors without control DNA. Diagn Mol Pathol, 21(3), 127-33. ()
    47. Chen R, Pan S, Ottenhof NA, de Wilde RF, Wolfgang CL, Lane Z, Post J, Bronner MP, Willmann JK, Maitra A, Brentnall TA (2012). Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biol Ther, 13(10), 899-907. ()
    48. Lai LA, Risques RA, Bronner MP, Rabinovitch PS, Crispin D, Chen R, Brentnall TA (2012). Pan-colonic field defects are detected by CGH in the colons of UC patients with dysplasia/cancer. Cancer Lett, 320(2), 180-8. ()
    49. Stevens T, Berk MP, Lopez R, Chung YM, Zhang R, Parsi MA, Bronner MP, Feldstein AE (2012). Lipidomic profiling of serum and pancreatic fluid in chronic pancreatitis. Pancreas, 41(4), 518-22. ()
    50. Lin J, Goldblum JR, Bennett AE, Bronner MP, Liu X (2012). Composite intestinal adenoma-microcarcinoid. Am J Surg Pathol, 36(2), 292-5. ()
    51. Brentnall TA, Lai LA, Coleman J, Bronner MP, Pan S, Chen R (2012). Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PLoS One, 7(1), e30219. ()
    52. Patil DT, Goldblum JR, Rybicki L, Plesec TP, Mendelin JE, Bennett AE, Castilla EA, Henricks WH, Schoenfield L, Skacel M, Yerian LM, Rice TW, Bronner MP, Downs-Kelly E (2012). Prediction of adenocarcinoma in esophagectomy specimens based upon analysis of preresection biopsies of Barrett esophagus with at least high-grade dysplasia: a comparison of 2 systems. Am J Surg Pathol, 36(1), 134-41. ()
    53. Bista RK, Brentnall TA, Bronner MP, Langmead CJ, Brand RE, Liu Y (2011). Using optical markers of nondysplastic rectal epithelial cells to identify patients with ulcerative colitis-associated neoplasia. Inflamm Bowel Dis, 17(12), 2427-35. ()
    54. Levi Z, Baris HN, Kedar I, Niv Y, Geller A, Gal E, Gingold R, Morgenstern S, Baruch Y, Leach BH, Bronner MP, Eng C (2011). Upper and Lower Gastrointestinal Findings in PTEN Mutation-Positive Cowden Syndrome Patients Participating in an Active Surveillance Program. Clin Transl Gastroenterol, 2, e5. ()
    55. Dumartin L, Whiteman HJ, Weeks ME, Hariharan D, Dmitrovic B, Iacobuzio-Donahue CA, Brentnall TA, Bronner MP, Feakins RM, Timms JF, Brennan C, Lemoine NR, Crnogorac-Jurcevic T (2011). AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Cancer Res, 71(22), 7091-102. ()
    56. Arrossi AV, Kariv Y, Bronner MP, Hammel J, Remzi FH, Fazio VW, Goldblum JR (2011). Backwash ileitis does not affect pouch outcome in patients with ulcerative colitis with restorative proctocolectomy. Clin Gastroenterol Hepatol, 9(11), 981-8. ()
    57. Morrison J, Bronner M, Leach BH, Downs-Kelly E, Goldblum JR, Liu X (2011). Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach. Scand J Gastroenterol, 46(11), 1340-8. ()
    58. Ondrejka SL, Schaeffer DF, Jakubowski MA, Owen DA, Bronner MP (2011). Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing? Am J Surg Pathol, 35(9), 1327-30. ()
    59. Shaheen NJ, Overholt BF, Sampliner RE, Wolfsen HC, Wang KK, Fleischer DE, Sharma VK, Eisen GM, Fennerty MB, Hunter JG, Bronner MP, Goldblum JR, Bennett AE, Mashimo H, Rothstein RI, Gordon SR, Edmundowicz SA, Madanick RD, Peery AF, Muthusamy VR, Chang KJ, Kimmey MB, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Dumot JA, Falk GW, Galanko JA, Jobe BA, Hawes RH, Hoffman BJ, Sharma P, Chak A, Lightdale CJ (2011). Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology, 141(2), 460-8. ()
    60. Pan S, Chen R, Crispin DA, May D, Stevens T, McIntosh MW, Bronner MP, Ziogas A, Anton-Culver H, Brentnall TA (2011). Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res, 10(5), 2359-76. ()
    61. Rice TW, Bronner MP (2011). The esophageal wall. Thorac Surg Clin, 21(2), 299-305, x. ()
    62. Boncher J, Bronner M, Goldblum JR, Liu X (2011). Reticulin staining clarifies florid benign signet ring cell change with mitotic activity in a penetrating gastric ulcer. Am J Surg Pathol, 35(5), 762-6. ()
    63. Risques RA, Lai LA, Himmetoglu C, Ebaee A, Li L, Feng Z, Bronner MP, Al-Lahham B, Kowdley KV, Lindor KD, Rabinovitch PS, Brentnall TA (2011). Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res, 71(5), 1669-79. ()
    64. May D, Pan S, Crispin DA, Lai K, Bronner MP, Hogan J, Hockenbery DM, McIntosh M, Brentnall TA, Chen R (2011). Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics. J Proteome Res, 10(1), 200-9. ()
    65. Rice TW, Bronner MP (2011). The Esophageal Wall. Chest Surg Clin N Am.
    66. Pan S, Chen R, Stevens T, Bronner MP, May D, Tamura Y, McIntosh MW, Brentnall TA (2011). Proteomics portrait of archival lesions of chronic pancreatitis. PLoS One, 6(11), e27574. ()
    67. Bronner MP, Skacel M, Crispin DA, Hoff PD, Emond MJ, Lai LA, Tubbs RR, OSullivan JN, Rabinovitch PS, Brentnall TA (2010). Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors. Mod Pathol, 23(12), 1624-33. ()
    68. Albashir S, Bronner MP, Parsi MA, Walsh RM, Stevens T (2010). Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis. Am J Gastroenterol, 105(11), 2498-503. ()
    69. Thompson OM, Beresford SA, Kirk EA, Bronner MP, Vaughan TL (2010). Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction. Obesity (Silver Spring), 18(11), 2204-11. ()
    70. Chen R, Crispin DA, Pan S, Hawley S, McIntosh MW, May D, Anton-Culver H, Ziogas A, Bronner MP, Brentnall TA (2010). Pilot study of blood biomarker candidates for detection of pancreatic cancer. Pancreas, 39(7), 981-8. ()
    71. Mahajan D, Bennett AE, Liu X, Bena J, Bronner MP (2010). Grading of gastric foveolar-type dysplasia in Barrett's esophagus. Mod Pathol, 23(1), 1-11. ()
    72. Shaheen NJ, Peery AF, Hawes RH, Rothstein RI, Spechler SJ, Galanko JA, Campbell M, Carr C, Fowler B, Walsh J, Siddiqui AA, Infantolino A, Wolfsen HC, Bronner MP, AIM Dysplasia Trial Investigators (2010). Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus. Endoscopy, 42, 790-799.
    73. Salk JJ, Salipante SJ, Risques RA, Crispin DA, Li L, Bronner MP, Brentnall TA, Rabinovitch PS, Horwitz MS, Loeb LA (2009). Clonal expansions in ulcerative colitis identify patients with neoplasia. Proc Natl Acad Sci U S A, 106(49), 20871-6. ()
    74. Ren DN, Kim IY, Koh SB, Chang SJ, Eom M, Yi SY, Seong SH, Kim MD, Bronner MP, Cho MY (2009). Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma. J Surg Oncol, 100(7), 546-52. ()
    75. Brentnall TA, Pan S, Bronner MP, Crispin DA, Mirzaei H, Cooke K, Tamura Y, Nikolskaya T, Jebailey L, Goodlett DR, McIntosh M, Aebersold R, Rabinovitch PS, Chen R (2009). Proteins That Underlie Neoplastic Progression of Ulcerative Colitis. Proteomics Clin Appl, 3(11), 1326. ()
    76. Kariv R, Plesec TP, Goldblum JR, Bronner M, Oldenburgh M, Rice TW, Falk GW (2009). The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol, 7(6), 653-8; quiz 606. ()
    77. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ (2009). Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med, 360(22), 2277-88. ()
    78. Reimel BA, Pan S, May DH, Shaffer SA, Goodlett DR, McIntosh MW, Yerian LM, Bronner MP, Chen R, Brentnall TA (2009). Proteomics on Fixed Tissue Specimens - A Review. Curr Proteomics, 6(1), 63-69. ()
    79. Pan S, Chen R, Reimel BA, Crispin DA, Mirzaei H, Cooke K, Coleman JF, Lane Z, Bronner MP, Goodlett DR, McIntosh MW, Traverso W, Aebersold R, Brentnall TA (2009). Quantitative proteomics investigation of pancreatic intraepithelial neoplasia. Electrophoresis, 30(7), 1132-44. ()
    80. Edelstein ZR, Bronner MP, Rosen SN, Vaughan TL (2009). Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. Am J Gastroenterol, 104(4), 834-42. ()
    81. Chu KE, Papouchado BG, Lane Z, Bronner MP (2009). The role of Movat pentachrome stain and immunoglobulin G4 immunostaining in the diagnosis of autoimmune pancreatitis. Mod Pathol, 22(3), 351-8. ()
    82. Bronner MP, Overholt BF, Taylor SL, Haggitt RC, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak MV, Nishioka N, Barr H, Canto MI, Marcon N, Pedrosa M, Grace M, Depot M (2009). Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology, 136(1), 56-64; quiz 351-2. ()
    83. Law R, Bronner M, Vogt D, Stevens T (2009). Autoimmune pancreatitis: a mimic of pancreatic cancer. Cleve Clin J Med, 76, 607-615.
    84. Xiao Z, Dasari VM, Kirby DF, Bronner MP, Plesec TP, Lashner BA (2009). Collagenous Sprue: A Case Report and Literature Review. Gastroenterol Hepatol (N Y), 5, 418-426.
    85. Koh PK, Doumit J, Downs-Kelly E, Bronner MP, Salimi R, Fazio VW, Vogel JD (2008). Ileo-anal j-pouch cancer: an unusual case in an unusual location. Tech Coloproctol, 12(4), 341-5. ()
    86. Bronner MP, OSullivan JN, Rabinovitch PS, Crispin DA, Chen L, Emond MJ, Rubin CE, Brentnall TA (2008). Genomic biomarkers to improve ulcerative colitis neoplasia surveillance. Am J Pathol, 173(6), 1853-60. ()
    87. Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM (2008). Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum, 51(12), 1750-6. ()
    88. Allende DS, Taylor SL, Bronner MP (2008). Colonic perforation as a complication of collagenous colitis in a series of 12 patients. Am J Gastroenterol, 103(10), 2598-604. ()
    89. Downs-Kelly E, Mendelin JE, Bennett AE, Castilla E, Henricks WH, Schoenfield L, Skacel M, Yerian L, Rice TW, Rybicki LA, Bronner MP, Goldblum JR (2008). Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol, 103(9), 2333-40; quiz 2341. ()
    90. Cho MY, Kim HS, Eng C, Kim DS, Kang SJ, Eom M, Yi SY, Bronner MP (2008). First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity. Am J Surg Pathol, 32(8), 1258-64. ()
    91. Risques RA, Lai LA, Brentnall TA, Li L, Feng Z, Gallaher J, Mandelson MT, Potter JD, Bronner MP, Rabinovitch PS (2008). Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology, 135(2), 410-8. ()
    92. Jobe BA, ORourke RW, McMahon BP, Gravesen F, Lorenzo C, Hunter JG, Bronner M, Kraemer SJ (2008). Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg, 248(1), 69-76. ()
    93. Overholt BF, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak MV Jr, Nishioka N, Barr H, Marcon N, Pedrosa M, Bronner MP, Grace M, Depot M (2007). Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc, 66(3), 460-8. ()
    94. Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL (2007). Central adiposity and risk of Barrett's esophagus. Gastroenterology, 133(2), 403-11. ()
    95. Chen R, Brentnall TA, Pan S, Cooke K, Moyes KW, Lane Z, Crispin DA, Goodlett DR, Aebersold R, Bronner MP (2007). Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics, 6(8), 1331-42. ()
    96. Nason KS, Farrow DC, Haigh G, Lee SP, Bronner MP, Rosen SN, Vaughan TL (2007). Gastric fluid bile concentrations and risk of Barrett's esophagus. Interact Cardiovasc Thorac Surg, 6(3), 304-7. ()
    97. Chen R, Pan S, Cooke K, Moyes KW, Bronner MP, Goodlett DR, Aebersold R, Brentnall TA (2007). Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas, 34(1), 70-9. ()
    98. Pogue-Geile KL, Chen R, Bronner MP, Crnogorac-Jurcevic T, Moyes KW, Dowen S, Otey CA, Crispin DA, George RD, Whitcomb DC, Brentnall TA (2006). Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med, 3(12), e516. ()
    99. Alexander J, Limaye AP, Ko CW, Bronner MP, Kowdley KV (2006). Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. Liver Transpl, 12(12), 1799-804. ()
    100. Chen R, Pan S, Yi EC, Donohoe S, Bronner MP, Potter JD, Goodlett DR, Aebersold R, Brentnall TA (2006). Quantitative proteomic profiling of pancreatic cancer juice. Proteomics, 6(13), 3871-9. ()
    101. OSullivan J, Risques RA, Mandelson MT, Chen L, Brentnall TA, Bronner MP, Macmillan MP, Feng Z, Siebert JR, Potter JD, Rabinovitch PS (2006). Telomere length in the colon declines with age: a relation to colorectal cancer? Cancer Epidemiol Biomarkers Prev, 15(3), 573-7. ()
    102. Chen R, Bronner MP, Crispin DA, Rabinovitch PS, Brentnall TA (2005). Characterization of genomic instability in ulcerative colitis neoplasia leads to discovery of putative tumor suppressor regions. Cancer Genet Cytogenet, 162(2), 99-106. ()
    103. Chen R, Yi EC, Donohoe S, Pan S, Eng J, Cooke K, Crispin DA, Lane Z, Goodlett DR, Bronner MP, Aebersold R, Brentnall TA (2005). Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology, 129(4), 1187-97. ()
    104. Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor SL, Grace MG, Depot M (2005). Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc, 62(4), 488-98. ()
    105. Robert ME, Washington MK, Lee JR, Goldenring JR, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart JA, Lamps LW, Lauwers GY, Lewin D, Lazenby AJ, Montgomery E, Crawford JM (2005). Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus. Am J Clin Pathol, 124(4), 519-27. ()
    106. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall TA (2005). The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis, 26(9), 1513-9. ()
    107. Mitomi H, Okayasu I, Bronner MP, Kanazawa H, Nishiyama Y, Otani Y, Sada M, Tanabe S, Igarashi M, Katsumata T, Saigenji K (2005). Comparative histologic assessment of proctocolectomy specimens from Japanese and American patients with ulcerative colitis with or without dysplasia. Int J Surg Pathol, 13(3), 259-65. ()
    108. Pickett CA, Agoff SN, Widman TJ, Bronner MP (2005). Altered expression of cyclins and cell cycle inhibitors in papillary thyroid cancer: prognostic implications. Thyroid, 15(5), 461-73. ()
    109. Rudolph RE, Dominitz JA, Lampe JW, Levy L, Qu P, Li SS, Lampe PD, Bronner MP, Potter JD (2005). Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol Biomarkers Prev, 14(3), 605-8. ()
    110. Bronner MP (2004). Granulomatous appendicitis and the appendix in idiopathic inflammatory bowel disease. Semin Diagn Pathol, 21(2), 98-107. ()
    111. Allison KH, Yoder BJ, Bronner MP, Goldblum JR, Rubin BP (2004). Angiosarcoma involving the gastrointestinal tract: a series of primary and metastatic cases. Am J Surg Pathol, 28(3), 298-307. ()
    112. Charpentier KP, Brentnall TA, Bronner MP, Byrd D, Marsh C (2004). A new indication for pancreas transplantation: high grade pancreatic dysplasia. Clin Transplant, 18(1), 105-7. ()
    113. Bronner MP, Goldblum JR (2004). Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Adv Anat Pathol, 11, 225-226.
    114. Akintola-Ogunremi O, Pfeifer JD, Tan BR, Yan Y, Zhu X, Hart J, Goldblum JR, Burgart L, Lauwers GY, Montgomery E, Lewin D, Washington K, Bronner M, Xiao SY, Greenson JK, Lamps L, Lazenby A, Wang HL (2003). Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas. Am J Surg Pathol, 27(12), 1551-8. ()
    115. Yuan S, Reyes V, Bronner MP (2003). Pseudomembranous collagenous colitis. Am J Surg Pathol, 27(10), 1375-9. ()
    116. Maronian N, Haggitt R, Oelschlager BK, Bronner M, Yang J, Reyes V, Hillel A, Eubanks T, Pellegrini CA, Pope CE 2nd (2003). Histologic features of reflux-attributed laryngeal lesions. Am J Med, 115 Suppl 3A, 105S-108S. ()
    117. Moskovitz AH, Linford NJ, Brentnall TA, Bronner MP, Storer BE, Potter JD, Bell RH Jr, Rabinovitch PS (2003). Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma. Genes Chromosomes Cancer, 37(2), 201-6. ()
    118. Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV (2003). Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology, 124(2), 318-26. ()
    119. Lamps LW, Madhusudhan KT, Havens JM, Greenson JK, Bronner MP, Chiles MC, Dean PJ, Scott MA (2003). Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn's disease. Am J Surg Pathol, 27(2), 220-7. ()
    120. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Koprowicz KM, Bronner MP, Brentnall TA (2003). DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am J Pathol, 162(2), 665-72. ()
    121. OSullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin DA, Potter JD, Rabinovitch PS (2002). Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet, 32(2), 280-4. ()
    122. Kimmey MB, Bronner MP, Byrd DR, Brentnall TA (2002). Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc, 56(4 Suppl), S82-6. ()
    123. Eberle MA, Pftzer R, Pogue-Geile KL, Bronner MP, Crispin D, Kimmey MB, Duerr RH, Kruglyak L, Whitcomb DC, Brentnall TA (2002). A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet, 70(4), 1044-8. ()
    124. Yen TW, Aardal NP, Bronner MP, Thorning DR, Savard CE, Lee SP, Bell RH Jr (2002). Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery, 131(2), 129-34. ()
    125. Montgomery E, Bronner MP, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Goldblum JR (2002). Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol, 97(1), 27-31. ()
    126. Meckler KA, Brentnall TA, Haggitt RC, Crispin D, Byrd DR, Kimmey MB, Bronner MP (2001). Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma. Am J Surg Pathol, 25(8), 1047-53. ()
    127. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA (2001). Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res, 61(9), 3573-7. ()
    128. Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE, Haggitt RC (2001). Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Mod Pathol, 14(3), 139-46. ()
    129. Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA (2001). Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med, 134(2), 89-95. ()
    130. Yasui Y, Potter JD, Stanford JA, Rossing MA, Winget MD, Bronner MP, Daling J (2001). Breast cancer risk and ‘delayed’ primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev, 10, 9-16.
    131. Bronner MP (2000). Rodger C. Haggitt: A biography. Hum Pathol, 31(10), 1185-7. ()
    132. Valdez R, Appelman HD, Bronner MP, Greenson JK (2000). Diffuse duodenitis associated with ulcerative colitis. Am J Surg Pathol, 24(10), 1407-13. ()
    133. Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, Haggitt RC, Reed MW, Afonina IA, Rabinovitch PS, Stevens AC, Feng Z, Bronner MP (2000). The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol, 157(3), 737-45. ()
    134. Anwar F, Emond MJ, Schmidt RA, Hwang HC, Bronner MP (2000). Retinoblastoma expression in thyroid neoplasms. Mod Pathol, 13(5), 562-9. ()
    135. Cotler SJ, Taylor SL, Gretch DR, Bronner MP, Rizk R, Perkins JD, Carithers RL Jr (2000). Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients. Am J Gastroenterol, 95(3), 753-9. ()
    136. Cotler SJ, Emond MJ, Gretch DR, Wilson JJ, Lin M, Bronner MP, Kowdley KV (1999). Relationship between iron concentration and hepatitis C virus RNA level in liver tissue. J Clin Gastroenterol, 29(4), 322-6. ()
    137. Rabinovitch PS, Dziadon S, Brentnall TA, Emond MJ, Crispin DA, Haggitt RC, Bronner MP (1999). Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res, 59(20), 5148-53. ()
    138. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB (1999). Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med, 131(4), 247-55. ()
    139. Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV (1999). Quantitative study of the variability of hepatic iron concentrations. Clin Chem, 45(3), 340-6. ()
    140. Cotler SJ, Gaur LK, Gretch DR, Wile M, Strong DM, Bronner MP, Carithers RL Jr, Emond MJ, Perkins JD, Nelson KA (1998). Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue Antigens, 52(5), 435-43. ()
    141. Cotler SJ, Bronner MP, Press RD, Carlson TH, Perkins JD, Emond MJ, Kowdley KV (1998). End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol, 29(2), 257-62. ()
    142. Lamps LW, Bronner MP, Vnencak-Jones CL, Tham KT, Mertz HR, Scott MA (1998). Optimal screening and diagnosis of microsporida in tissue sections: a comparison of polarization, special stains, and molecular techniques. Am J Clin Pathol, 109(4), 404-10. ()
    143. Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, Emerson SS, Perkins JD, Carithers RL Jr (1997). Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology, 26(6), 1646-52. ()
    144. Cotler SJ, Gretch DR, Bronner MP, Tateyama H, Emond MJ, dela Rosa C, Perkins JD, Carithers RL Jr (1997). Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients. Hepatology, 26(2), 432-6. ()
    145. Kendrick EA, McVicar JP, Kowdley KV, Bronner MP, Emond MJ, Alpers CE, Gretch DR, Carithers RL Jr, Perkins JD, Davis CL (1997). Renal disease in hepatitis C-positive liver transplant recipients. Transplantation, 63(9), 1287-93. ()
    146. Stehman-Breen CO, Psaty BM, Emerson S, Gretch D, Bronner MP, Marsh C, Davis CL (1997). Association of hepatitis C virus infection with mortality and graft survival in kidney pancreas transplant recipients. Transplantation, 64, 281-286.
    147. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggitt RC, Boland CR (1996). Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res, 56(6), 1237-40. ()
    148. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, Kowdley KV, Stevens AC, Crispin DA, Emond M, Rubin CE (1996). Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology, 110(2), 331-8. ()
    149. Bell K, Bronner MP, Pasha T, Furth EE (1996). Expression of proliferating cell nuclear antigen in gastrointestinal tract lesions and its relationship to bcl-2 expression. Pathobiology, 64(2), 91-8. ()
    150. MacCalman CD, Furth EE, Omigbodun A, Bronner M, Coutifaris C, Strauss JF (1996). Regulated expression of Cadherin-11 in human epithelial cells: A role for Cadherin-11 in trophoblast-endometrium interactions? Dev Dyn, 206, 201-211.
    151. Brentnall TA, Chen R, Lee JG, Kimmey MB, Bronner MP, Haggitt RC, Kowdley KV, Hecker LM, Byrd DR (1995). Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res, 55(19), 4264-7. ()
    152. Brentnall TA, Rubin CE, Crispin DA, Stevens A, Batchelor RH, Haggitt RC, Bronner MP, Evans JP, McCahill LE, Bilir N (1995). A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology, 109(1), 151-5. ()
    153. Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh CL (1995). Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. Clin Transplant, 9(1), 53-9. ()
    154. Bronner MP, Culin C, Reed JC, Furth EE (1995). The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol, 146(1), 20-6. ()
    155. Wittmaack FM, Gafvels ME, Bronner M, Matsuo H, McCrae KR, Tomaszewski JE, Robinson SL, Strickland DK, Strauss JF 3rd (1995). Localization and regulation of the human very low density lipoprotein/apolipoprotein-E receptor: trophoblast expression predicts a role for the receptor in placental lipid transport. Endocrinology, 136(1), 340-8. ()
    156. Bronner MP, Hamilton R, LiVolsi VA (2020). Utility of frozen section analysis on follicular lesions of the thyroid. Endocr Pathol, 5(3), 154-161. ()
    157. Sakuragi N, Matsuo H, Coukos G, Furth EE, Bronner MP, VanArsdale CM, Krajewsky S, Reed JC, Strauss JF 3rd (1994). Differentiation-dependent expression of the BCL-2 proto-oncogene in the human trophoblast lineage. J Soc Gynecol Investig, 1(2), 164-72. ()
    158. Kido S, Sakuragi N, Bronner MP, Sayegh R, Berger R, Patterson D, Strauss JF 3rd (1993). D21S418E identifies a cAMP-regulated gene located on chromosome 21q22.3 that is expressed in placental syncytiotrophoblast and choriocarcinoma cells. Genomics, 17(1), 256-9. ()
    159. Bronner MP, LiVolsi VA (1991). Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Mod Pathol, 4(5), 637-43. ()
    160. Levine MS, Barnes MJ, Bronner MP, Rubesin SE, Saul SH (1990). Atypical hyperplastic polyps at double-contrast barium enema examination. Radiology, 175(3), 691-4. ()
    161. Rubesin SE, Gilchrist AM, Bronner MP, Saul SH, Herlinger H, Grumbach K, Levine MS, Laufer I (1990). Non-Hodgkin lymphoma of the small intestine. Radiographics, 10, 985-998.
    162. Bronner MP, Clevenger CV, Edmonds PR, Lowell DM, McFarland MM, LiVolsi VA (1988). Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid. Am J Clin Pathol, 89(6), 764-9. ()
    163. Bronner MP, LiVolsi VA, Jennings TA (1988). PLAT: Paraganglioma-Like Adenomas of the Thyroid. 1, 383-389.
    164. Bronner MP, LiVolsi VA (1988). Oxyphilic (Askanazy/Hürthle cell) tumors of the thyroid: Microscopic features predict biologic behavior. 1, 137-150.

    Review

    1. Bronner MP (2003). Gastrointestinal polyposis syndromes. [Review]. Am J Med Genet A, 122A(4), 335-41. ()
    2. Bronner MP (2003). Gastrointestinal inherited polyposis syndromes. [Review]. Mod Pathol, 16(4), 359-65. ()
    3. Bronner MP (1997). Hürthle cell lesions of the thyroid. [Review]. Pathol Case Rev, 2, 200-209.

    Book Chapter

    1. Bronner MP (2008). Histopathology of Gastroesophageal Reflux Disease and Barrett’s Esophagus. In Pearson FG (honorary editor), Patterson A, Cooper J, Deslauriers J, Lerut T, Luketich J, Rice T (Eds.), Pearson’s Textbook Of Esophageal Surgery (3rd, 2, pp. 395-414). Philadelphia: Churchhill Livingstone Elsevier Publishing.
    2. Bronner MP (2007). Pathology of Hereditary Colorectal Cancer. In Church J, Burke CA (Eds.), Hereditary Colorectal Cancer Syndromes (1st). Blackwell Publishing.
    3. Bronner MP, Geisinger KR (2006). The esophagus. In Silverberg SG, deLellis RA, Frable WJ, LiVolsi VA, Wick MR (Eds.), Silverberg's Principles and Practice of Surgical Pathology and Cytopathology (pp. 1281-1319). Philadelphia: Churchill Livingstone.
    4. Bronner MP (2003). Inflammatory Disorders of the Gastrointestinal Tract: Esophagus. In Odze RD, Crawford JM, Goldblum JR (Eds.), Surgical Pathology of the Gastrointestinal Tract, Liver, Biliary Tract and Pancreas (1st). Orlando: W.B. Saunders Company.
    5. Rubin CE, Bronner MP (2003). Endoscopic mucosal biopsy. In Yamada T (Ed.), Textbook of Gastroenterology (4th). Philadelphia: Lippincott Williams and Wilkins.
    6. Bronner MP, Haggitt RC, Rubin CE (1998). Endoscopy and Endoscopic Biopsy. In Ming S-C,Goldman H (Eds.), Pathology of the Gastrointestinal Tract (2nd, pp. 35-46). Baltimore: Williams and Wilkins.
    7. Bronner MP, Haggitt RC (1993). The polyp-cancer sequence: Do all colorectal cancers arise from benign adenomas? In Bond JH (Ed.), Gastrointestinal Endoscopy Clinics of North America (3, pp. 611-724). Philadelphia: W. B. Saunders Company.
    8. Rubesin SE, Bronner MP (1991). Radiologic-Pathologic Concepts in Crohn's Disease. In Herlinger H, Megibow A (Eds.), Advances in Gastrointestinal Radiology (1, pp. 27-55). Mosby-Year Book, Inc.

    Case Report

    1. Grant GA, Wener MH, Yaziji H, Futran N, Bronner MP, Mandel N, Mayberg MR (1999). Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature. J Neurosurg, 90(1), 148-52. ()

    Editorial

    1. Bronner MP (1999). Gastric cancer and intestinal metaplasia. 30(7), 733.

    Letter

    1. Lennerz JK, Pantanowitz L, Amin MB, Eltoum IE, Hameed MR, Kalof AN, Khanafshar E, Kunju LP, Lazenby AJ, Montone KT, Otis CN, Reid MD, Staats PN, Whitney-Miller CL, Abendroth CS, Aron M, Birdsong GG, Bleiweiss IJ, Bronner MP, Chapman J, Cipriani NA, de la Roza G, Esposito MJ, Fadare O, Ferrer K, Fletcher CD, Frishberg DP, Garcia FU, Geldenhuys L, Gill RM, Gui D, Halat S, Hameed O, Hornick JL, Huber AR, Jain D, Jhala N, Jorda M, Jorns JM, Kaplan J, Khalifa MA, Khan A, Kim GE, Lee EY, LiVolsi VA, Longacre T, Magi-Galluzzi C, McCall SJ, McPhaul L, Mehta V, Merzianu M, Miller SB, Molberg KH, Moreira AL, Naini BV, Nos V, OToole K, Picken M, Prieto VG, Pullman JM, Quick CM, Reynolds JP, Rosenberg AE, Schnitt SJ, Schwartz MR, Sekosan M, Smith MT, Sohani A, Stowman A, Vanguri VK, Wang B, Watts JC, Wei S, Whitney K, Younes M, Zee S, Bracamonte ER (2022). Ensuring remote diagnostics for pathologists: an open letter to the US Congress. [Letter to the editor]. Nat Med, 28(12), 2453-2455. ()
    2. Pan S, Brand RE, Lai LA, Dawson DW, Donahue TR, Kim S, Khalaf NI, Othman MO, Fisher WE, Bronner MP, Simeone DM, Brentnall TA, Chen R (2021). Proteome heterogeneity and malignancy detection in pancreatic cyst fluids. [Letter to the editor]. Clin Transl Med, 11(8), e506. ()
    3. Bronner MP, Goldblum JR, Kimmey MB, Brentnall TA, Rubin CE (2004). Low-grade dysplasia in ulcerative colitis: natural history data still unknown. [Letter to the editor]. Gastroenterology, 127(1), 362-3; author reply 363-4. ()
    4. Raaka S, Huehnergarth KV, Kowdley KV, Bronner MP (2002). Tissue typing for HFE mutations. [Letter to the editor]. Hepatology, 35(4), 977-8. ()
    5. Haggitt RC, Bronner MP, Rubin CE (1999). More biopsies per block. [Letter to the editor]. Am J Clin Pathol, 112(6), 878-81. ()

    Abstract

    1. Bronner MP, Saul SH (1987). Biliary cystadenomas with mesenchymal stroma. [Abstract]. ASCP Check Sample, 15, 1-7.

    Patent

    1. Brentnall T, Chen R, Pogue-Geile K, Whitcomb D, Bronner M, Otey C (2010). Composition and Methods for Detecting Cancer. U.S. Patent No. 7,851,144 B2. Washington, D.C.:U.S. Patent and Trademark Office.